The Pharmacy Times® Cardiovascular Health Resource Center is a comprehensive resource for clinical news and expert insights on the health of the heart and blood vessels, including coronary heart disease, stroke, heart failure, heart arrhythmias, and heart valve issues.
July 9th 2025
The 2025 National Lipid Association (NLA) Scientific Sessions highlighted a strategic shift toward early, aggressive cardiometabolic intervention, underscoring the vital role of pharmacists in implementing emerging therapies and optimizing cardiovascular risk reduction.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care an...
1.0 Credit / Cardiology, Endocrinology, Diabetes, & Metabolism, Nephrology
View More
Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes
1.5 Credits / Cardiology
View More
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
1.0 Credit / Cardiology
View More
Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-Syst...
1.5 Credits / Cardiology, Patient Safety
View More
Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines
1.0 Credit / Cardiology
View More
Hyperlipidemia Overview and the Clinical and Economic Burden
1.0 Credit / Cardiology
View More
Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence
0.5 Credit / Cardiology
View More
The Role of the Pharmacist in the Management of Hyperlipidemia
1.0 Credit / Cardiology
View More
Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative
1.5 Credits / Cardiology
View More
The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies
1.5 Credits / Cardiology, Rare Diseases
View More
Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies
1.5 Credits / Pulmonology, Cardiology, Rare Diseases
View More
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
0.75 Credit / Oncology, Law
View More
Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines
1.0 Credit / Cardiology
View More
The Role of IV Iron in Resolving Iron Deficiency in Heart Failure
1.0 Credit / Cardiology, Gastroenterology, General Pharmacy, Oncology, Women's Health
View More
From Guidelines to Practice: The Pharmacist’s Role in Chronic Heart Failure Therapy Optimization
1.5 Credits / Cardiology
View More
Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies
1.5 Credits / Cardiology
View More
Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases
1.0 Credit / General Pharmacy, Law
View More
Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)
1.0 Credit / General Pharmacy, Law
View More
Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer
1.0 Credit / Cardiology, Gastroenterology, General Pharmacy, Oncology, Women's Health
View More
Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease
1.0 Credit / Cardiology, Gastroenterology, General Pharmacy, Oncology, Women's Health
View More
Iron Deficiency Anemia Treatment Considerations in Women’s Health
1.0 Credit / Cardiology, Gastroenterology, General Pharmacy, Oncology, Women's Health
View More
Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene
1.0 Credits / Cardiology, Nephrology
View More
NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction
June 2nd 2025Bempedoic acid is an effective option for statin-intolerant patients or those needing additional low-density lipoprotein cholesterol (LDL-C) reduction, with clinical trials showing cardiovascular benefits, key drug-drug interaction considerations, and special management factors in patients with comorbidities.
Read More
NLA 2025: GLP-1 Therapies May Impact Cardiovascular and Renal Health Independent of Weight Loss
May 31st 2025GLP-1 receptor agonists, including semaglutide and tirzepatide, significantly reduce cardiometabolic risk factors such as dyslipidemia, type 2 diabetes, metabolic dysfunction-associated steatohepatitis, obstructive sleep apnea, chronic kidney disease, and cardiovascular events, with evidence suggesting that some of these benefits may occur independently of weight loss.
Read More
FDA Approves Treprostinil Inhalation Powder for PAH and PH-ILD
May 27th 2025The approval is based on findings from the INSPIRE trial, where treprostinil demonstrated efficacy in pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Read More
ACC 2025: Intravenous Iron Safe, but Results in Mixed Findings for Patients With Heart Failure
March 30th 2025Patients in the treatment group had a 21% lower risk of cardiovascular death or first heart failure hospitalization overall, but the between-group difference did not meet the threshold for statistical significance for this primary end point.
Read More